跳至主要内容
临床试验/TCTR20160910002
TCTR20160910002已完成3 期

Randomized double-blind study of efficacy and safety of topical 3% minoxidil solution combined with 0.25% finasteride solution versus 3% minoxidil solution in treatment of male androgenetic alopecia

Division of Dermatology, Ramathibodi Hospital, Mahidol University0 个研究点目标入组 40 人开始时间: 2016年9月10日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
Male

入选标准

  • 1.Healthy male subject
  • 2.Diagnosis of androgenic alopecia with class III and V Norwood-Hamilton classification
  • 3.Agree to participate and signed informed consent form

排除标准

  • 1.History of hair transplant
  • 2.Applying topical hair growth products within 2 weeks
  • 3.Receiving light and laser treatment of the scalp within 3 months
  • 4.Taking oral finasteride within 12 months
  • 5.Taking dutasteride within 18 months
  • 6.History of systemic illness
  • 7.History of scalp diseases eg. seborrheic dermatitis, scalp infection.

研究者

发起方
Division of Dermatology, Ramathibodi Hospital, Mahidol University

相似试验